Contract Services
Mayne Pharma plans to double oral-dose manufacturing space and expand contract services.
/ read more /
Recipharm will be responsible for the supply of the remaining clinical-trial material and ongoing future commercial supply of RHB-105, the lead drug candidate developed by RedHill for the treatment of Helicobacter pylori bacterial infection.
/ read more /
WuXi's Laboratory Testing Division will be the exclusive supplier of laboratory testing services for Hong Kong-based Lee's Pharm.
/ read more /
Cytovance Biologics anticipates continued expansion plans following acquisition by Hepalink USA.
/ read more /
With this acquisition, Source BioScience is now able to offer integrated solutions to customers, with environmentally controlled storage in combination with the required up- or downstream analytical testing services.
/ read more /
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.
/ read more /
Companies in the US will now have the opportunity to tap into Hermes Pharma’s technical expertise in effervescent and chewable tablets, instant drinks, lozenges, and orally disintegrating granules (ODGs).
/ read more /
Catalent selects advisory board members to complement Redwood Bioscience Scientific Advisory Board.
/ read more /
|